FDA clears mobile 1.5T MRI system

For patients in rural areas who may not have access to MRI services, the U.S. Food and Drug Administration (FDA) has opened the door for one to come to you.

Siemens Healthineers’s MAGNETOM Viato.Mobile 1.5 Tesla MRI, announced late last year, has received 510(k) clearance from the FDA. The machine is designed to be transported to an off-site location, effectively providing access to MRI scans from anywhere.

The MAGNETOM Viato.Mobile system is contained in a trailer that can be parked at hospitals, health systems, or clinics either as an additional machine for overloaded radiology units or as a dedicated MRI system for facilities that may not have the budget or space to build the necessary shielded room.

According to a statement from Siemens sent to Health Imaging, the mobile scanner offers some of the same features of larger systems, including AI to accelerate brain scans, reduce noise and artifacts, and ultimately improve image resolution. There is also technology that Siemens says helps the system to adapt to the physiology of a patient, to personalize a scan for better image results.

There is also an on-board guidance system to assist radiology technicians in performing a scan, catered to their experience level. This is useful for areas that may have trained radiologists who don’t get to perform MRI scans very often due to a lack of access to a fixed unit.

In the statement announcing the FDA clearance, Jane Kilkenny, vice president of magnetic resonance at Siemens Healthineers, said the company is dedicated to mobile imaging and providing people, regardless of location, access to the latest technology.

“The introduction of the MAGNETOM Viato.Mobile is yet another example of our efforts to democratize high-end imaging technology to provide greater access to care,” she said.

Siemens received FDA clearance for other models of its MAGNETOM MRI system in 2021 and 2022

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.